Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
This study aims to assess the tolerability of duloxetine, 60mg once daily, in open label
fashion, in depressed patients with Parkinson's disease during 12 weeks treatment.